Loading
Paediatric oncologist who chairs the world's largest childhood cancer research organisation.
Douglas Hawkins is Group Chair of the Children's Oncology Group (COG) and Professor of Pediatrics at Seattle Children's and the University of Washington, with ties to Fred Hutchinson Cancer Center. A paediatric oncologist specialising in bone and soft-tissue sarcomas, he led COG Ewing sarcoma trials and has chaired the Children's Oncology Group since 2020. His papers include a Journal of Clinical Oncology review of current management and collaborative future approaches in Ewing sarcoma and a COG report that adding vincristine and irinotecan to standard chemotherapy did not improve outcome in intermediate-risk rhabdomyosarcoma. His record links to the Euro Ewing 2012 trial.
| Title | Journal | Year |
|---|---|---|
| Ewing Sarcoma: Current Management and Future Approaches Through Collaboration | Journal of Clinical Oncology | 2015 |
| Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group | Journal of Clinical Oncology | 2018 |
Shares Children's Oncology Group (COG), Sarcomas (soft tissue, bone, GIST).
Shares Euro Ewing 2012, Children's Oncology Group (COG), Sarcomas (soft tissue, bone, GIST).
Shares Children's Oncology Group (COG), Sarcomas (soft tissue, bone, GIST).
Shares Children's Oncology Group (COG), Sarcomas (soft tissue, bone, GIST).
Shares Children's Oncology Group (COG), Sarcomas (soft tissue, bone, GIST).
Shares Children's Oncology Group (COG), Sarcomas (soft tissue, bone, GIST).
Shares Children's Oncology Group (COG), Sarcomas (soft tissue, bone, GIST).
Shares Children's Oncology Group (COG), Sarcomas (soft tissue, bone, GIST).